Stephen C. Bain
Active 1994–2025
- 102
- Papers
- 22,668
- Citations
- 57
- h-index
- 95
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine81.5%
- Biochemistry, Genetics and Molecular Biology13%
- Immunology and Microbiology1.2%
- Neuroscience1.2%
- Health Professions0.6%
- Pharmacology, Toxicology and Pharmaceutics0.4%
- Other2.1%
Topics
- Diabetes Treatment and Management18.6%
- Diabetes Management and Research6.9%
- Pancreatic function and diabetes6.4%
- Metabolism, Diabetes, and Cancer4.9%
- Pharmacology and Obesity Treatment3.4%
- Bariatric Surgery and Outcomes3.3%
- Other56.5%
Coauthors
- Søren Rasmussen17
- John B. Buse13
- Richard E. Pratley10
- Anthony Barnett9
- John A. Todd9
- Michael A. Nauck9
- Richard M. Bracken9
- Johannes F.E. Mann8
- Ofri Mosenzon8
- Bernard Zinman7
- Dipesh Patel7
- Ildiko Lingvay7
- Lawrence A. Leiter7
- Mansoor Husain7
- Subodh Verma7
- Tina Vilsbøll7
- Neil R Poulter6
- Olivia McCarthy6
- Tahseen A Chowdhury6
- Adnan Sharif5
- Andrew Frankel5
- Debasish Banerjee5
- Francesco Cucca5
- Indranil Dasgupta5
All papers
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Authors: Steven P. Marso, Stephen C. Bain, Agostino Consoli, Freddy G. Eliaschewitz, Esteban Jódar, Lawrence A. Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark Warren, Vincent Woo, Oluf H. Hansen, Anders G. Holst, Jonas Pettersson, Tina Vilsbøll - New England Journal of Medicine 2016 cited by 6,603
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Authors: Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G. Eliaschewitz, Denise Reis Franco, Ole Kleist Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D. Pedersen, Cees J. Tack, Mette S. Thomsen, Tina Vilsbøll, Mark Warren, Stephen C. Bain - New England Journal of Medicine 2019 cited by 1,932
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Authors: Christopher Sorli, Shin‐ichi Harashima, George Tsoukas, Jeffrey Unger, Julie Derving Karsbøl, Thomas K. Hansen, Stephen C. Bain - The Lancet Diabetes & Endocrinology 2017 cited by 707
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Authors: Carel W. le Roux, Arne Astrup, Ken Fujioka, Frank L. Greenway, David Lau, Luc Van Gaal, Rafael Violante Ortíz, John Wilding, Trine Vang Skjøth, Linda Shapiro Manning, F. Xavier Pi‐Sunyer, A. Hamann, Alain Barakat, Matthias Blüher, Thomas Linn, Andrea Mölle, Alexander Segner, Petra Stübler, Regina Tosch-Sisting, Furio Pacini, Ferruccio Santini, Giulio Marchesini, Carlo Maria Rotella, Cecilia Invitti, Roberto Vettor, Silvio Buscemi, Pedro Mezquita Raya, Felipe Casanueva Freijoo, Ramón Gomis de Barbará, Raffaele Carraro, Enrique Romero Bobillo, Carmen de la Cuesta, Csaba Farsang, Albert Császár, Barbara Zahorska‐Markiewicz, Danuta Pupek-Musialik, Edward Franek, Lucyna Ostrowska, Magdalena Olszanecka‐Glinianowicz, Nebojša Lalić, Dragan Micić, Bernhard Ludvik, Bernhard Paulweber, Rudolf Prager, André Scheen, Luc Van Gaal, Arne Astrup, Kjeld Hermansen, Sten Madsbad, Aila Rissanen, Sakari Nieminen, Markku J. Savolainen, Michel Krempf, Monique Romon, M. Laville, Michel Marre, R Mira, Francis Finucane, Aletha Veenendaal, Frank van Berkum, Solrun Johannsson-Vidarsdóttir, V. Van de Walle, Eelco W. Meesters, Jøran Hjelmesæth, Tor Ole Klemsdal, Bård Kulseng, Birgit Bach-Kliegel, Kurt Laederach, Lukas Villiger, Alain Golay, Stefan Bilz, Thozhukat Sathyapalan, Stephen C. Bain, Sudhesh Kumar, Carel Wynard le Roux, Michael E. J. Lean, Barbara McGowan, Michael E.J. Lean, John Wilding, Gary Wittert, Ian Caterson, Joeseph Proietto, John Prins, Bruno Geloneze Neto, Jorge Luiz Gross, Antônio Roberto Chacra, Alfredo Halpern, Henrique Suplicy, Francis Chun Chung Chow, Hemant Thacker, Manoj Chadha, Hemaraj Chandalia, AG Unnikrishnan, Sanjay Kalra, Neeta Deshpande, Minakshi Shunmugavelu, Vaishali Deshmukh, Maximo Maislos, G. Lieberman, Ilan Shimon and 104 more - The Lancet 2017 cited by 844
- A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
Authors: Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi - Diabetes Metabolic Syndrome and Obesity 2021 cited by 427
- Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Authors: Ahmed M. Shaman, Stephen C. Bain, George L. Bakris, John B. Buse, Thomas Idorn, Kenneth W. Mahaffey, Johannes F.E. Mann, Michael A. Nauck, Søren Rasmussen, Peter Rossing, Benjamin Ole Wolthers, Bernard Zinman, Vlado Perkovic - Circulation 2021 cited by 238
- Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Authors: Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh, John Deanfield, Silvio E. Inzucchi, Rodica Pop‐Busui, Johannes F.E. Mann, Scott S. Emerson, Neil R Poulter, Mads D.M. Engelmann, Maria Sejersten Ripa, G. Kees Hovingh, Kirstine Brown‐Frandsen, Stephen C. Bain, Matthew A. Cavender, Mette Gislum, Jens‐Peter David, John B. Buse - New England Journal of Medicine 2025 cited by 301
- Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Authors: Vanita R. Aroda, Stephen C. Bain, Bertrand Cariou, Milivoj Piletič, Ludger Rose, Mads Axelsen, Everton Rowe, J. Hans DeVries - The Lancet Diabetes & Endocrinology 2017 cited by 443
- A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
Authors: Marc Evans, Ruth D. Lewis, Angharad R. Morgan, Martin Whyte, Wasim Hanif, Stephen C. Bain, Sarah Davies, Umesh Dashora, Zaheer Yousef, Dipesh Patel, W. David Strain - Advances in Therapy 2021 cited by 305
- Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
Authors: Tina Vilsbøll, Stephen C. Bain, Lawrence A. Leiter, Ildiko Lingvay, David Matthews, Rafael Simó, Ida Carøe Helmark, Nelun Wijayasinghe, Michael Larsen - Diabetes Obesity and Metabolism 2017 cited by 294
- The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Authors: Thinzar Min, Stephen C. Bain - Diabetes Therapy 2020 cited by 273
- Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review
Authors: Stephen C. Bain, Michael A. Klufas, Allen C. Ho, David Matthews - Diabetes Obesity and Metabolism 2018 cited by 293
- Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo
Authors: Katherine R. Tuttle, Heidrun Bosch‐Traberg, David Z.I. Cherney, Samy Hadjadj, Jack Lawson, Ofri Mosenzon, Søren Rasmussen, Stephen C. Bain - Kidney International 2023 cited by 126
- Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Authors: Julio Rosenstock, Stephen C. Bain, Amoolya Gowda, Esteban Jódar, Bo Liang, Ildiko Lingvay, Tomoyuki Nishida, Roberto Trevisan, Ofri Mosenzon - New England Journal of Medicine 2023 cited by 149
- Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
Authors: Matthias von Herrath, Stephen C. Bain, Bruce W. Bode, Jesper O. Clausen, Ken Coppieters, Leylya Gaysina, Janusz Gumprecht, Troels Krarup Hansen, Chantal Mathieu, Cristóbal Morales, Ofri Mosenzon, Stine Segel, George Tsoukas, Thomas R. Pieber, Bernhard Ludvik, Rudolf Prager, Bernhard Paulweber, Christoph Ebenbichler, Bart Keymeulen, Christophe De Block, Loren D. Grossman, Robyn L. Houlden, Patrice Perron, Thomas Ransom, Peter Senior, S. John Weisnagel, Vincent Woo, R Dumas, David Thompson, Tina Vilsbøll, Jeppe Gram, Claus Bogh Juhl, Janne Hukkanen, Jorma Lahtela, Leo Niskanen, Donal O’Shea, Timothy O’Brien, Séamus Sreenan, Julio Wainstein, Moshe Phillip, Hilla Knobler, Francesco Dotta, Pier Marco Piatti, Roberto Trevisan, Agostino Gnasso, Hanne L. Gulseth, John Cooper, Ewa Pańkowska, Monika Łukaszewicz, Bogumił Wolnik, Isabel Manita, Olinda Marques, Cristina Roque, Rosa Maria Príncipe, Celestino Neves, Susana Heitor, L. A. Ruyatkina, I. V. Dvoryashina, Gulnar Vagapova, Lidiya Belousova, M. Sergeeva-Kondrachenko, А. Б. Песков, Elena Frolova, Albina Golovach, М. А. Куницына, N Krasnopeeva, Irina Ipatko, Carmen De la Cuesta, Francisco J. Tinahones, Mercedes Rigla, Juan Francisco Merino-Torres, Luis Alberto Gómez, Mercè Fernández, Rafael Simó, Mikael Rydén, Johan Jendle, Karin Filipsson, Björn Eliasson, Borys Mankovsky, Iurii Lymar, Liubov Sokolova, Galyna Myshanych, Tetiana Zlova, М.V. Vlasenkо, Petro Kuskalo -, Hamish Courtney, Colin Dayan, Patrick English, Simon Heller, A.B. Johnson, Sunil Nair, Richard David Leslie, Parth Narendran, Nick Oliver, Shenaz Ramtoola, J. H. F. Shaw, Adie Viljoen, Amer Al‐Karadsheh, Jean M. Dostou, Sumana Gangi and 13 more - The Lancet Diabetes & Endocrinology 2021 cited by 178
- Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
Authors: Mansoor Husain, Stephen C. Bain, Ole Kleist Jeppesen, Ildiko Lingvay, Rasmus Sørrig, Marianne Bach Treppendahl, Tina Vilsbøll - Diabetes Obesity and Metabolism 2020 cited by 209
- Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
Authors: John B. Buse, Stephen C. Bain, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock, Neil R Poulter, Richard E. Pratley, Martin Linder, Tea Monk Fries, David D. Ørsted, Bernard Zinman - Diabetes Care 2020 cited by 169
- Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Authors: Steven P. Marso, Florian M.M. Baeres, Stephen C. Bain, Bryan Goldman, Mansoor Husain, Michael A. Nauck, Neil R Poulter, Richard E. Pratley, Anne Bloch Thomsen, John B. Buse - Journal of the American College of Cardiology 2020 cited by 111
- The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
Authors: Ketan Dhatariya, Stephen C. Bain, John B. Buse, Richard J. Simpson, Lise Tarnow, Margit S. Kaltoft, Michael Stellfeld, Karen Tornøe, Richard E. Pratley - Diabetes Care 2018 cited by 131
- Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
Authors: Melanie J. Davies, Stephen C. Bain, Stephen L. Atkin, Peter Rossing, David A. Scott, Минара Шамхаловна Шамхалова, Heidrun Bosch‐Traberg, Annika Syrén, Guillermo E. Umpierrez - Diabetes Care 2015 cited by 228
- Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
Authors: Subodh Verma, Darren K. McGuire, Stephen C. Bain, Deepak L. Bhatt, Lawrence A. Leiter, C. David Mazer, Tea Monk Fries, Richard E. Pratley, Søren Rasmussen, Hrvoje Vražić, Bernard Zinman, John B. Buse - Diabetes Obesity and Metabolism 2020 cited by 93
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Authors: Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. Bain, Serge Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén, Anna Maria Langkilde, DEPICT-2 Investigators, Cecilia Luquez, Federico Pérez Manghi, María Rosa Ulla, Maria Alejandra Moisello, Virginia Visco, Silvia Gorban De Lapertoza, Silvana Ernestina Solís, Javier Farias, Georgina Sposetti, Pieter Gillard, Pascale Abrams, M. van Ypersele de Strihou, James R. W. Conway, Sue D. Pedersen, Peter Senior, Joanne Liutkus, Churn-Ern Yip, Zubin Punthakee, Frédéric Bernier, Heather Lochnan, Vincent Woo, Thomas G. Elliott, Juan Palma, C Merino, Alfredo Danin Vargas, Ulrich Wendisch, Andreas Reichel, Jochen Seufert, Bernd Becker, Hasan Alawi, Andreas L. Birkenfeld, Christoph Hasslacher, Joerg Luedemann, Thomas Schaum, Cornelia Marck, Joachim Sauter, Ulrich Aigner, Yukiko Onishi, Hiroaki Seino, Yuichi Sato, Kiyohide Nunoi, Akira Yamauchi, Eitaro Nakashima, Hiroki Ikeda, Toshihiko Shiraiwa, Yoshimitsu Yamasaki, Hiroki Yokoyama, Kunihiko Nakamura, Masayuki Noritake, Shozo Miyauchi, Tomomi Hakoda, Yoshihide Hirohata, Atsushi Hasegawa, Yoshihide Fukumoto, Hirotaka Nagashima, Masahiro Takihata, Tetsuro Kamada, Hideaki Jinnouchi, Yuri Ono, Takayuki Watanabe, Hiroshi Ohashi, Masahiko Takai, T Seguchi, Katsuya Yamazaki, Hajime Maeda, Shingo Iwasaki, Harold W. de Valk, Adriaan Kooy, S.A.N.T. Landewé-Cleuren, Katarzyna Madziarska, Andrzej Stankiewicz, Katarzyna Wasilewska, Gottfried Rudofsky, Maciej T. Małecki, Ewa Pańkowska, Ewa Szyprowska, Monika Łukaszewicz, Lidia Tokarska, Ирина Аркадьевна Бондарь, I. V. Karpova, Ludmila Ruyatkina, Alsu Gafurovna Zalevskaya, Ruslan Sardinov, Yury Khalimov, Folke Sjöberg, Pekka Koskinen and 63 more - Diabetes Care 2018 cited by 252
- Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
Authors: Lawrence A. Leiter, Stephen C. Bain, Irene Hramiak, Esteban Jódar, Sten Madsbad, Theis Gondolf, Thomas K. Hansen, Ingrid Holst, Ildiko Lingvay - Cardiovascular Diabetology 2019 cited by 162
- Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
Authors: Subodh Verma, Neil R Poulter, Deepak L. Bhatt, Stephen C. Bain, John B. Buse, Lawrence A. Leiter, Michael A. Nauck, Richard E. Pratley, Bernard Zinman, David D. Ørsted, Tea Monk Fries, Søren Rasmussen, Steven P. Marso - Circulation 2018 cited by 119
